Related Experiment Videos
Coxsackieviral replication and pathogenicity: lessons from gene modified animal models
1Deutsches Herzzentrum and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Lazarettstrasse 36, 80636 Munich, Germany rwessely@dhm.mhn.de
Medical Microbiology and Immunology
|October 28, 2003
Summary
Low levels of persistent coxsackieviral genomes can cause dilated cardiomyopathy in mice. Type I interferons are crucial for controlling viral replication and survival during coxsackieviral infections.
Area of Science:
- Virology
- Cardiology
- Immunology
Background:
- Coxsackieviruses are linked to human myocarditis and dilated cardiomyopathy.
- Animal models, especially gene-targeted mice, are vital for understanding viral heart disease.
- Viral persistence and host immune responses are key factors in pathogenesis.
Purpose of the Study:
- To review cell culture and transgenic animal models of coxsackieviral persistence.
- To investigate the link between persistent viral genomes and cardiac pathology.
- To elucidate the role of innate immunity, specifically interferon signaling, in coxsackieviral infection.
Main Methods:
- Utilized cell culture models to study coxsackieviral persistence.
- Employed transgenic mice to mimic viral persistence and cardiac effects.
- Examined gene-targeted mice deficient in type I or type II interferon signaling.
Main Results:
- Low levels of persistent, replication-restricted coxsackieviral genomes induced a cytopathic effect in cardiac myocytes.
- A transgenic mouse model exhibited a phenotype closely resembling human dilated cardiomyopathy.
- Type I interferons, but not type II, were essential for controlling early viral replication and survival.
Conclusions:
- Persistent coxsackieviral genomes, even at low levels, can lead to dilated cardiomyopathy.
- Transgenic mouse models effectively replicate key features of human dilated cardiomyopathy.
- Type I interferon signaling is critical for host defense against coxsackieviral infections.